What the Data Actually Shows
The attachments include multiple public datasets — including U.S., U.K., France, and Canada comparisons of death and hospitalization rates by vaccination status.
Across these independent national databases, the pattern is consistent during peak waves:
• Higher hospitalization rates among unvaccinated populations
• Higher ICU admissions among unvaccinated groups
• Higher mortality rates per 100,000 among unvaccinated groups
For example, U.K. Health Security Agency data during late 2021 waves showed significantly elevated death rates in older unvaccinated cohorts compared to double-vaccinated groups. U.S. CDC-linked mortality charts during the Delta and Omicron waves showed a similar divergence.
Are vaccines risk-free? No medical intervention is. Rare adverse effects, including clotting disorders, myocarditis, and allergic reactions, were documented. Large-scale reviews, including analyses published in The Lancet, estimate serious clotting risks in the range of approximately 1–2 cases per million doses for certain vaccine types.
Risk exists. But risk magnitude matters.
Population-level analysis consistently demonstrated that the risk of severe COVID-19 complications significantly exceeded the risk of serious vaccine adverse events during peak transmission periods.
That does not invalidate individual experiences. It contextualizes them.
The mRNA “Dual Use” Argument
Some replies suggest mRNA technology was never “just a vaccine,” but a dual-use biodefense architecture capable of genetic modulation.
This is where technical precision becomes essential.
mRNA vaccines do not alter DNA. They deliver transient instructions to cells to produce a viral protein (the spike protein), which then triggers an immune response. The mRNA degrades within days. It does not integrate into the genome under normal biological processes.
mRNA platforms have been studied for decades in cancer therapy, influenza research, and biodefense contexts because they can be rapidly designed once a pathogen’s genetic sequence is known.
Rapid deployability does not equate to covert genetic manipulation. It reflects modular biomedical design.
Claims of “programmable payloads for population control” have not been substantiated by peer-reviewed evidence.
